GUIDED THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
GUIDED THERAPEUTICS, INC. (GTHP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price of $0.26 per share for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice · last filed 2024-03-28
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2023-03-31 was $0.31.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2021-03-31 was $0.00.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2017-03-31 was $14000.00, a 32458.14% increase year-over-year.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2023 was $0.26.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2021 was $0.49.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2020 was $0.00.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2017 was $48613.00, a 34.45% decline from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.26 10-K · filed 2024-03-28 | |||
| 2023-09-30 | $0.31 10-Q · filed 2023-11-13 | |||
| 2023-06-30 | $0.31 10-Q · filed 2023-08-10 | |||
| 2023-03-31 | $0.31 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $0.49 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $0.48 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-18 | |||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-21 | |||
| 2020-12-31 | $0.00 10-K · filed 2021-04-07 | |||
| 2020-09-30 | $0.00 10-Q/A · filed 2020-11-05 | |||
| 2018-09-30 | $37090.00 10-Q · filed 2018-11-14 | |||
| 2018-06-30 | $37090.00 10-Q · filed 2018-08-14 | |||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-21 | |||
| 2017-12-31 | $48613.00 10-K/A · filed 2018-04-20 | |||
| 2017-09-30 | $55200.00 10-Q · filed 2017-11-20 | |||
| 2017-06-30 | $55200.00 10-Q · filed 2017-08-18 | |||
| 2017-03-31 | $14000.00 10-Q · filed 2017-05-22 | |||
| 2016-12-31 | $74160.00 10-K/A · filed 2018-04-20 | |||
| 2016-09-30 | $74160.00 10-Q · filed 2016-12-05 | |||
| 2016-06-30 | $71.16 10-Q · filed 2016-08-17 | |||
| 2016-03-31 | $43.00 10-Q · filed 2016-05-19 | |||
| 2015-12-31 | $38400.00 10-K · filed 2017-03-22 |